Actos Bladder Cancer Symptoms

In announcing that Actos use for more than a year may be linked to an increased risk of bladder cancer, the FDA provided updated information for both patients and healthcare professionals. In its Actos bladder cancer announcement, the FDA advised Actos users to contact their doctors immediately if they develop any of the following bladder cancer symptoms:

• Back or lower abdominal pain
• Blood in the urine
• Red-tinted urine
• Urgent need to urinate
• Pain during urination

The FDA advised that these symptoms may indicate bladder cancer and recommended that doctors counsel their patients to report any of these symptoms immediately.

If your doctor has diagnosed you with bladder cancer and you used ActoPlus Met, ActoPlus Met XR, or Duetact, you may have legal recourse to seek compensation for your medical bills and other losses. To find out if you qualify, complete our free, no obligation case review form today.

Actos Bladder Cancer Information

In addition to cautioning Actos users on the signs of bladder cancer, the FDA also made additional recommendations to patients in light of research which revealed an Actos bladder cancer link. The agency warned patients that there may be an increased chance of developing bladder cancer when using Actos, and this drug should not be taken in those who are receiving treatment for bladder cancer. (Patients should not, however, stop taking any medications without first speaking with their doctors.) Likewise, the agency warned healthcare professionals to not use Actos in patients with active bladder cancer and to prescribe it with caution in patients with a history of the disease. According to the FDA, the benefits of the drug verses its unknown risk for the recurrence of bladder cancer with Actos use should be weighed in individuals with a prior history of bladder cancer.

Actos Lawsuits: Bladder Cancer

Shortly after the Actos bladder cancer announcement, thousands of patients reportedly contacted attorneys regarding their eligibility for legal recourse. If the manufacturer of this drug failed to adequately warn of the public of this risk, patients who took ActoPlus Met, ActoPlus Met XR, or Duetact and were diagnosed with bladder cancer may be able to file an Actos lawsuit seeking compensation for medical bills, lost wages and other damages. There is a time limit for filing these claims, so patients are advised to act quickly. To receive a no cost, no obligation review of your Actos bladder cancer claim, simply complete our free case review form today.